252 related articles for article (PubMed ID: 36706802)
21. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
[TBL] [Abstract][Full Text] [Related]
22. Curcumol Alleviates the Inflammation of Nucleus Pulposus Cells via the PI3K/Akt/NF-κB Signaling Pathway and Delays Intervertebral Disk Degeneration.
He S; Fu Y; Yan B; Tan H; Li H; Li J; Huang D; Huang Z; Lai J; Feng H; Sun Z; Lan Z
World Neurosurg; 2021 Nov; 155():e402-e411. PubMed ID: 34450323
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
[TBL] [Abstract][Full Text] [Related]
24. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
[TBL] [Abstract][Full Text] [Related]
25. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
Wang HM; Wang Y; Liu M; Bai Y; Zhang XH; Sun YX; Wang HL
Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
[TBL] [Abstract][Full Text] [Related]
26. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats.
Chen L; Xiao J; Li Y; Ma H
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):1-7. PubMed ID: 21381494
[TBL] [Abstract][Full Text] [Related]
27. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
Chen YJ; Li HF; Zhao FR; Yu M; Pan SY; Sun WZ; Yin YY; Zhu TT
Int Immunopharmacol; 2024 May; 132():111946. PubMed ID: 38552292
[TBL] [Abstract][Full Text] [Related]
28. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
[TBL] [Abstract][Full Text] [Related]
29. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
30. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
[TBL] [Abstract][Full Text] [Related]
31. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
[TBL] [Abstract][Full Text] [Related]
32. Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.
Wang YY; Cheng XD; Jiang H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10549-10556. PubMed ID: 31841211
[TBL] [Abstract][Full Text] [Related]
33. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
[TBL] [Abstract][Full Text] [Related]
34. Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
Li N; Su S; Xie X; Yang Z; Li Z; Lu D
J Ethnopharmacol; 2024 Feb; 320():117436. PubMed ID: 37979813
[TBL] [Abstract][Full Text] [Related]
35. miR‑371b‑5p inhibits endothelial cell apoptosis in monocrotaline‑induced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
Zhu G; Zhang W; Liu Y; Wang S
Mol Med Rep; 2018 Dec; 18(6):5489-5501. PubMed ID: 30387816
[TBL] [Abstract][Full Text] [Related]
36. Pinocembrin attenuates susceptibility to atrial fibrillation in rats with pulmonary arterial hypertension.
Yi Y; Tianxin Y; Zhangchi L; Cui Z; Weiguo W; Bo Y
Eur J Pharmacol; 2023 Dec; 960():176169. PubMed ID: 37925134
[TBL] [Abstract][Full Text] [Related]
37. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
38. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats.
Lan TH; Chen XL; Wu YS; Qiu HL; Li JZ; Ruan XM; Xu DP; Lin DQ
Eur J Pharmacol; 2018 Jun; 829():102-111. PubMed ID: 29665366
[TBL] [Abstract][Full Text] [Related]
39. Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation.
Ambade AS; Jung B; Lee D; Doods H; Wu D
Transl Res; 2019 Jan; 203():15-30. PubMed ID: 30142307
[TBL] [Abstract][Full Text] [Related]
40. 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats.
Gu C; Yang Z; Su S; Ma K; Nan X; Li Z; Lu D
Toxicol Appl Pharmacol; 2023 Aug; 473():116596. PubMed ID: 37328117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
